FDA clears Thermi in “ vaginal rejuvenation ” product inquiry
Temp-controlled radiofrequency tech developer Thermi said this week that the FDA granted it a notice of completion following an inquiry on products used in “vaginal rejuvenation” procedures. Irving, Texas-based Thermi received a notice from the FDA on July 24 regarding specific claims about the company’s ThermiVa device. The ThermiVa is a non-ablative RF device cleared by the FDA for use in dermatological and general surgical procedures for electrocoagulation and hemostasis. The ThermiVa is intended to be used in in-office treatments using temperature-controlled RF energy to gently heat tissue, Thermi sai...
Source: Mass Device - November 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Women's Health Thermi Source Type: news

FDA authorizes digital Ebola test for emergency use, data on Omada's diabetes prevention program, and more digital health news briefs
Also:  L’Oréal unveils UV sensor clip, companion app; Urinary incontinence wearable receives De Novo clearance.  (Source: mobihealthnews)
Source: mobihealthnews - November 14, 2018 Category: Information Technology Source Type: news

Urinary Incontinence Common in Women Over 50 Years
FRIDAY, Nov. 9, 2018 -- Nearly half of women older than 50 years report having urinary incontinence, according to the results of the National Poll on Healthy Aging, published on Nov. 1. The University of Michigan Institute for Healthcare Policy and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 9, 2018 Category: Pharmaceuticals Source Type: news

Many Women Over 50 Have Urinary Incontinence, Most Don't Seek Treatment Many Women Over 50 Have Urinary Incontinence, Most Don't Seek Treatment
Nearly half of women over age 50 report bladder leakage and many say it's a major problem for them, according to a new U.S. survey.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 6, 2018 Category: Allergy & Immunology Tags: Urology News Source Type: news

Men are ‘willing to risk earlier deaths to avoid surgery for prostate cancer'
A study found that they were concerned about the impact on their sex lives and the possibility of incontinence. (Source: the Mail online | Health)
Source: the Mail online | Health - November 5, 2018 Category: Consumer Health News Source Type: news

Valencia Techs updates on eCoin OAB trials
Valencia Technologies this week updated on the pivotal trial of its eCoin overactive bladder neurostim device, saying it has enrolled more than 35 patients and that it expects to finish implantations by January next year, with a hopeful completion date of January 2020. The system, which is approximately the size of a nickel, is designed to implanted in a 10 minute procedure and send electrical impulses to the tibial nerve to stimulate the part of the brain that controls bladder response, the New York-based company said. The single-arm pivotal trial, which won approval by the FDA in March, aims to enroll a total of 120...
Source: Mass Device - November 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Featured Urology Valencia Technologies Source Type: news

Medibio names medical-device veteran Kaysen CEO
Medibio Ltd., which develops technology that aims to diagnose mental-health conditions, has named medical-device industry veteran David Kaysen its CEO and managing director. Kaysen was most recently CEO of a Sun BioPharma Inc., a biotech company developing drugs to treat diseases affecting the pancreas. He was previously the top executive at medical-device maker Uroplasty Inc., which makes devices that treated overactive bladder and incontinence. (He's also the father of renowned Minneapolis chef… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 2, 2018 Category: Pharmaceuticals Authors: Katharine Grayson Source Type: news

Axonics closes $120m IPO
Axonics Modulation Technologies (NSDQ:AXNX) today closed its $120 million initial public offering, saying it could reap still more from the flotation if an underwriters option is exercised. Irvine, Calif.-based Axonics, which makes the r-SNM device sacral neuromodulation system for treating overactive bladder, fecal incontinence and urinary retention, had set the range for the flotation at $93.3 million to $106.7 million, but later increased the number of shares to 8 million, priced at $15 each. The 30-day, 1.2-million-share over-allotment, if fully exercised, would add $18 million to the IPO&...
Source: Mass Device - November 2, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Initial Public Offering (IPO) Neuromodulation/Neurostimulation Wall Street Beat Axonics Modulation Technologies Source Type: news

Poll: Women Don't Talk to Docs About Incontinence
In a new poll, 43 percent of women in their 50s and 60s had urinary incontinence. That percentage jumped to 51 percent among those over 65. But two-thirds of those women had not discussed the problem with a doctor. (Source: WebMD Health)
Source: WebMD Health - November 1, 2018 Category: Consumer Health News Source Type: news

About half of women above age 50 have incontinence but most are too embarrassed to speak to a doctor
A new survey from the University of Michigan found that only 38 percent of women who have urinary incontinence perform Kegel exercises, which strengthen the pelvic muscles. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2018 Category: Consumer Health News Source Type: news

Half of Older Women Suffer Incontinence, Many Don't Tell Their Doc
THURSDAY, Nov. 1, 2018 -- Nearly half of older American women have urinary incontinence, but many have not talked to a doctor about it, a new national poll shows. More than 1,000 women, aged 50 to 80, were asked questions about their bladder... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 1, 2018 Category: General Medicine Source Type: news

Half of Older Women Suffer Incontinence, Many Don't Tell Their Doc
Title: Half of Older Women Suffer Incontinence, Many Don't Tell Their DocCategory: Health NewsCreated: 11/1/2018 12:00:00 AMLast Editorial Review: 11/1/2018 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - November 1, 2018 Category: OBGYN Source Type: news

Poll: Half of women over 50 experience incontinence, but most haven't talked to a doctor
(Michigan Medicine - University of Michigan) Nearly half of women over 50 say they sometimes leak urine according to a new national poll. Of more than 1,000 women between the ages of 50 and 80 who answered the poll, 43 percent of women in their 50s and early 60s said they had had experienced urinary incontinence, as had 51 percent of those age 65 and over. Yet two-thirds of these women hadn't talked to a doctor about the issue. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 1, 2018 Category: International Medicine & Public Health Source Type: news

Axonics prices upsized $120m offering
Axonics Modulation Technologies yesterday priced an upsized initial public offering that could fetch a maximum of $138 million. Irvine, Calif.-based Axonics, which makes the r-SNM device sacral neuromodulation system for treating overactive bladder, fecal incontinence and urinary retention, last week set the range for the flotation at $93.3 million to $106.7 million, saying it would issue nearly 6.7 million shares at $14 to $16 apiece. Yesterday the company increased the number of shares to 8 million, priced at $15 each, for gross proceeds of $120 million. If a 30-day, 1.2-million-share over-a...
Source: Mass Device - October 31, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Initial Public Offering (IPO) MassDevice Earnings Roundup Neuromodulation/Neurostimulation Wall Street Beat Axonics Modulation Technologies Source Type: news

Outcomes Studied for Surgical Tx of Stress Urinary Incontinence
THURSDAY, Oct. 25, 2018 -- Among women undergoing midurethral mesh sling insertion, the rate of mesh sling removal at nine years is estimated to be 3.3 percent, according to a study published online Oct. 23 in the Journal of the American Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 25, 2018 Category: Pharmaceuticals Source Type: news

Axonics sets range for $100m IPO
Axonics Modulation Technologies yesterday set the range on an initial public offering that would fetch $100 million at the midpoint. The Irvine, Calif.-based company makes the r-SNM device sacral neuromodulation system for treating overactive bladder, fecal incontinence and urinary retention. Axonics touts it as the first such rechargeable device; it’s designed to deliver mild electrical stimulation using a four-electrode lead introduced through the sacrum and a pulse generator implanted in the upped buttocks. Axonics said it plans to float nearly 6.7 million shares at $14 to $16 apiece, for a gro...
Source: Mass Device - October 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Neuromodulation/Neurostimulation Wall Street Beat Axonics Modulation Technologies Source Type: news

How do pelvic floor muscle exercises reduce overactive bladder symptoms?
(Wolters Kluwer Health) Overactive bladder (OAB) is a common form of urinary incontinence that is widely treated with pelvic floor muscle (PFM) training. A new laboratory study lends insights into how PFM training works: by reducing contractions of the detrusor muscle of the bladder, reports the American Journal of Physical Medicine& Rehabilitation, the official journal of the?Association of Academic Physiatrists. The journal is published by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2018 Category: International Medicine & Public Health Source Type: news

DFree, a smartphone-connected wearable for incontinence, launches in US
San Diego-based Triple W has launched a new wearable connected health monitor in the United States, focused on urinary incontinence. The sensor, called DFree, uses an ultrasound sensor to monitor changes in bladder size. Then proprietary algorithms translate that data into information about when a user should head to the bathroom. (Source: mobihealthnews)
Source: mobihealthnews - October 16, 2018 Category: Information Technology Source Type: news

Boston Scientific touts 3-year Solyx stress urinary incontinence mesh trial data
Boston Scientific (NYSE:BSX) this week released three-year data from a study of its Solyx single incision sling system intended to treat stress urinary incontinence, touting that the trial met all primary and secondary endpoints. Boston Scientific said it presented the full results from the trial yesterday at the annual scientific symposium of the American Urogynecologic Society. The Marlborough, Mass.-based company said it enrolled a total 281 patients in the trial at 21 sites looking to compare efficacy and adverse events for non-inferiority of the Solyx system versus the gold-standard transobturator mid-urethr...
Source: Mass Device - October 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Featured Urology Women's Health Boston Scientific Source Type: news

C-Sections Have Nearly Doubled Since 2000. That Isn ’t Necessarily A Good Thing
Nearly twice as many babies were born via caesarean sections (C-sections) in 2015 as in 2000, a new report says. Almost 30 million C-sections were performed globally in 2015, accounting for 21% of all live births, according to World Health Organization and UNICEF data published Thursday in the Lancet. In 2000, 16 million babies were delivered by C-section, accounting for 12% of live births. The uptick in C-sections — and the persistent disparities in where they’re performed — points to two connected trends, the authors write. On one hand, the growth signifies that more women are giving birth under medical...
Source: TIME: Health - October 11, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime maternal health Source Type: news

Getting relief from sexual dysfunction and incontinence caused by menopause
(The North American Menopause Society (NAMS)) Microablative fractional CO2 lasers are energy-based devices designed to help manage troublesome menopause symptoms such as painful sex, dryness, itching/burning, urinary frequency, and incontinence. Although there is ongoing debate regarding the safety and effectiveness of vaginal laser surgery, a new study suggests that it may be effective, especially after multiple treatments. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2018 Category: International Medicine & Public Health Source Type: news

Featured Review: Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
Chantal Dumoulin andLicia P Cacciari fromCochrane Incontinence  wanted to find out if pelvic floor muscle training (PFMT) helps women with urinary incontinence problems. They did this by comparing the effects of this training with no treatment, or with any inactive treatment (for example, advice on management with pads). We asked Chantal and Lucia questions a bout this recentCochrane Review.1.Please can you describe yourself and your Cochrane Group?Since 2012 I have held a Canada Research Chair in Urogyneacoogical health and Aging. Our research program's overarching goal is toImprove continence care in older Canadian ...
Source: Cochrane News and Events - October 9, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Axonics Modulation files for $86m IPO
Axonics Modulation Technologies last week registered for an initial public offering worth more than $86 million for its neuromodulation system for treating urinary and bowel conditions. The Irvine, Calif.-based company touts its r-SNM device as the first rechargeable sacral neuromodulation system for treating overactive bladder, fecal incontinence and urinary retention. It’s designed to deliver mild electrical stimulation using a four-electrode lead introduced through the sacrum and a pulse generator implanted in the upped buttocks. Th r-SNM device won CE Mark approval in the European Union in June 201...
Source: Mass Device - October 9, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Initial Public Offering (IPO) Neuromodulation/Neurostimulation Wall Street Beat Axonics Modulation Technologies Source Type: news

Surgical mesh last resort for prolapse or incontinence
Only consider mesh or tape when all other non-surgical options have failed or are not possible Related items fromOnMedica Midwife-led birth safest for straightforward pregnancy Doctors campaign against ‘too much medicine’ Eight in ten stillbirths might have been avoided Hunt announces Medicines and Medical Devices Safety Review Hospitals failing to prevent cardiac arrests (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 9, 2018 Category: UK Health Source Type: news

Mesh 'last option' for incontinence
The controversial treatment should only be considered when other options have failed, says watchdog. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 8, 2018 Category: Consumer Health News Source Type: news

FODMAP Diet Helps Fecal Incontinence
(MedPage Today) -- Two-thirds of patients reported improvements and more than one-third had complete remission (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 8, 2018 Category: Gastroenterology Source Type: news

Obesity Doubles Risk of Incontinence in Younger Women Obesity Doubles Risk of Incontinence in Younger Women
Clinicians should counsel women that maintaining a healthy weight may help prevent urinary incontinence now or later in life, the authors suggest.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - September 20, 2018 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news

Obesity Doubles Risk for Incontinence in Younger Women Obesity Doubles Risk for Incontinence in Younger Women
Clinicians should counsel women that maintaining a healthy weight may help prevent urinary incontinence now or later in life, the authors suggest.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 20, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Primary Care Doctors Less Familiar With Vaginal Atrophy Primary Care Doctors Less Familiar With Vaginal Atrophy
Postmenopausal women who experience problems like vaginal dryness, painful intercourse or urinary incontinence may want to see a gynecologist instead of a primary care provider for help, a recent study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Overweight and obesity linked to higher risk of urinary incontinence for women
(Wiley) Being overweight or obese is linked with an increased risk of developing urinary incontinence for young to mid-aged women, according to an Obesity Reviews analysis of all relevant published studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 19, 2018 Category: International Medicine & Public Health Source Type: news

Women's sexual health after menopause may be best treated by gynecologists
(Reuters Health) - Postmenopausal women who experience problems like vaginal dryness, painful intercourse or urinary incontinence may want to see a gynecologist instead of a primary care provider for help, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - September 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Failure rate in some surgical mesh treatments unacceptably high - Biomedical review
(Trinity College Dublin) Failure rates in some surgical mesh products used to treat prolapse injury are unacceptably high according to a new biomedical review conducted by a medical materials expert, who also believes patients should have received more information around the risk before being treated for urinary incontinence with surgical mesh products. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2018 Category: International Medicine & Public Health Source Type: news

Viveve Sets Its Sights on SUI Indication Target
Viveve Medical has its eyes set on getting approval for a device to treat stress urinary incontinence (SUI). The Englewood, CO-based company has submitted an IDE application into FDA to get authorization to begin the LIBERATE-U.S. clinical trial. LIBERATE is intended to be a randomized, double-blinded, and sham-controlled trial with enrollment of about 240 subjects at up to 25 study sites in the US. Subjects will be randomized in a 2:1 ratio for active and sham treatments. The trial will evaluate the safety and efficacy of the company’s proprietary, cryogen-cooled monopolar radiofrequency (CMRF) technolog...
Source: MDDI - September 11, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Featured Review: Interventions for preventing falls in older people in care facilities and hospitals
How effective are interventions designed to reduce falls in older people in care facilities and hospitals?Falls by older people in care facilities, such as nursing homes, and hospitals are common events that may cause further loss of independence, injuries, and sometimes death as a result of injury. Effective interventions to prevent falls are therefore important.Many types of interventions are in use. These include:exercisemedication interventions that include vitamin D supplementationmedication review of the drugs that people are takingenvironment or assistive technologies including bed or chair alarms or the use of spec...
Source: Cochrane News and Events - September 7, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Robot-Assisted Implantation of Artificial Urinary Sphincter Feasible in Women Robot-Assisted Implantation of Artificial Urinary Sphincter Feasible in Women
Robot assistance helps make laparoscopic implantation of the AMS-800 artificial urinary sphincter (AUS) from Boston Scientific a practical approach to treating women with stress urinary incontinence, according to French researchers.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 6, 2018 Category: Surgery Tags: Urology News Source Type: news

Health Tip: Understanding Urinary Incontinence
-- Urinary incontinence is the loss of bladder control, a common concern for people as they get older. Millions of adults in the United States have urinary incontinence, more often women than men. Treatment varies based on the problem's severity,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 6, 2018 Category: General Medicine Source Type: news

Health Tip: Understanding Urinary Incontinence
Title: Health Tip: Understanding Urinary IncontinenceCategory: Health NewsCreated: 9/6/2018 12:00:00 AMLast Editorial Review: 9/6/2018 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - September 6, 2018 Category: OBGYN Source Type: news

Experts Highlight Best Practices for Managing Incontinence
Four experts addressed evidence-based recommendations for assessing and treating urinary and fecal incontinence among older individuals in the PA/LTC setting at AMDA – the Society for Post-Acute and Long-Term Care Medicine’s Annual Conference. (Source: Caring for the Ages)
Source: Caring for the Ages - September 1, 2018 Category: Health Management Authors: Brian Ellis Source Type: news

BlueWind posts positive follow-up study results
BlueWind Medical’s implantable tibial stimulation device Neurostim developer BlueWind Medical reported positive results from a follow-up study of patients using its implantable tibial nerve stimulator for overactive bladder (OAB). Renova iStim is a leadless, miniature, wireless neurostimulation platform designed for the treatment of multiple clinical indications. Three years after implantation of the BlueWind’s Renova iStim device, 75% of patients experienced at least a 50% long-term reduction in symptoms. Patients experienced a durable, long-term, effect of urinary urge incontinence relief in &l...
Source: Mass Device - August 31, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Food & Drug Administration (FDA) Implants Neuromodulation/Neurostimulation Research & Development Urology Bluewind Medical Source Type: news

Atlantic Therapeutics touts muscle stimulation device for urinary incontinence
Atlantic Therapeutics‘ Innovo shorts beat intravaginal probe devices at keeping women with stress urinary incontinence dry in an FDA-designed clinical trial. An externally worn electrical muscle stimulation device, Innovo demonstrated greatly reduced risk of infection and improved user tolerability over the intravaginal devices, according to research presented this week at the International Continence Society meeting in Philadelphia. Get the whole story at our sister site, Medical Design & Outsourcing. The post Atlantic Therapeutics touts muscle stimulation device for urinary incontinence appeared first on M...
Source: Mass Device - August 29, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Food & Drug Administration (FDA) Research & Development Urology Women's Health atlantictherapeutics Source Type: news

Renovia Brings in $42.3M for Its Series B Round
Boston-based Renovia has just brought in a rather sizeable financing. The company has raised about $42.3 million in a series B round. The financing will accelerate clinical research, development and new digital therapeutic device launches that are focused on pelvic floor disorders. The series B financing was led by Perceptive Advisors and Ascension Ventures, with participation from Longwood Fund, Inova Strategic Investments, Cormorant Asset Management, OSF Ventures and Western Technology Investment. BayCross Capital Group acted as an advisor to Renovia. “Combining our innovative and proprietary sensor tec...
Source: MDDI - August 22, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Time to tackle ‘taboo’ over continence issues, warn charities
Leading charities are calling for more research into issues surrounding incontinence, as they highlighted that it was one of the biggest issues for many with serious health conditions. (Source: Nursing Times)
Source: Nursing Times - August 22, 2018 Category: Nursing Source Type: news

Renovia is flush with cash after $42m Series B
Women’s health company Renovia has raised $42.3 million in financing to support clinical trials, product and corporate development and future commercial launches, the company said in a statement. The funding includes $32.3 million in Series B equity and $10 million in venture debt. An SEC filing in July revealed that the company had raised $25.3 million in equity financing. Boston-based Renovia created and produces the Leva pelvic floor strengthening system designed to aid individuals suffering from pelvic floor disorders. The system contains sensor technology that allows the user to see the position o...
Source: Mass Device - August 21, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Women's Health renovia Source Type: news

WPSI Recommends Annual Urinary Incontinence Screening
TUESDAY, Aug. 21, 2018 -- The Women's Preventive Services Initiative (WPSI) recommends annual urinary incontinence screening for women and referral for further evaluation and treatment if indicated, according to a clinical guideline published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2018 Category: Pharmaceuticals Source Type: news

Health Tip: Keep Your Bladder Healthier
-- Each day, adults pass about 1.5 quarts of urine through the bladder, the National Institute on Aging says. Keeping your bladder healthy can help prevent infection and incontinence, which tend to become more common as you age, the agency says. It... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 20, 2018 Category: General Medicine Source Type: news

Viveve launches woman-focused stress urinary incontinence device trial
Viveve (NSDQ:VIVE) said on Tuesday it launched a trial exploring the safety and efficacy of its cryogen-cooled monopolar radiofrequency tech designed to treat stress urinary incontinence in women. The new Liberate trial will look to enroll 100 subjects at up to 10 sites in Canada, with patients randomized in a two-to-one ratio for active and sham treatments. The Englewood, Colo.-based company said that the first subject in the trial has had their first visit under an approved Investigational Testing Application with the Canadian Ministry of Health and central investigatioal review board approval. “Initiatio...
Source: Mass Device - August 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Urology Women's Health Viveve Source Type: news

Vaginal Rejuvenation Manufacturers Land in Hot Water with FDA
 Back in February, MD+DI got the low down from an obstetrics and gynecologist specialist in Lubbock, TX on a new vaginal rejuvenation device that her patients have been raving about.  Now it seems the manufacturer of that particular device, along with other companies selling laser- or energy-based devices for vaginal rejuvenation failed to get FDA's blessing. "We've recently become aware of a growing number of manufacturers marketing 'vaginal rejuvenation' devices to women and claiming these procedures will treat conditions and symptoms related to menopause, urinary incontinence, or...
Source: MDDI - August 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

New Guidelines for Urinary Incontinence Screenings
Title: New Guidelines for Urinary Incontinence ScreeningsCategory: Health NewsCreated: 8/13/2018 12:00:00 AMLast Editorial Review: 8/14/2018 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - August 14, 2018 Category: OBGYN Source Type: news

Guideline: Screen All Women Yearly for Urinary Incontinence Guideline: Screen All Women Yearly for Urinary Incontinence
A new guideline from the Women's Preventive Services Initiative recommends yearly screening for urinary incontinence for women of all ages; however, editorialists say this recommendation is premature.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

New Guidelines Push for Routine Incontinence Screening in All Women
(MedPage Today) -- Recommendation not supported by direct evidence (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - August 13, 2018 Category: OBGYN Source Type: news